Nothing Special   »   [go: up one dir, main page]

Wilner et al., 1971 - Google Patents

Aggregation of platelets by collagen: polar active sites of insoluble human collagen

Wilner et al., 1971

Document ID
670114171584341787
Author
Wilner G
Nossel H
Procupez T
Publication year
Publication venue
American Journal of Physiology-Legacy Content

External Links

Snippet

MATERIALS AND METHODS Venous blood was drawn from normal subjects using disposable 20-gauge needles and polypropylene syringes (Roehr Products Co., Deland, Fla). The blood was anticoagulated with 0.1 volume of 1% solution of sodium heparin …
Continue reading at journals.physiology.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Wilner et al. Aggregation of platelets by collagen: polar active sites of insoluble human collagen
Laki et al. Chemistry and physiology of the fibrinogen-fibrin transition
Rubin et al. Effects of pepsin treatment on the interaction properties of tropocollagen macromolecules
Brass et al. The role of collagen quaternary structure in the platelet: collagen interaction
Stathakis et al. Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma
Davies et al. The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis
Bang et al. Thrombosis and bleeding disorders: theory and methods
Alexander et al. The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin
Edsall et al. Chemical, clinical, and immunological studies on the products of human plasma fractionation. XV. The proteins concerned in the blood coagulation mechanism
Ouyang et al. Purification and properties of the thrombin-like principle of Agkistrodon acutus venom and its comparison with bovine thrombin
Wilhelm et al. Enzyme-like Globulins from Serum Reproducing the Vascular Phenomena of Inflammation: II. Isolation and Properties of the Permeability Factor and Its Inhibitor
Mann et al. The molecular weights of bovine thrombin and its primary autolysis products
Lewis et al. Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials
Blumberg et al. Further evidence on the protein complexes of some hyaluronic acids
Nanninga et al. Preparation and properties of anticoagulant split product of fibrinogen and its determination in plasma
Ouyang et al. Properties of fibrinogen degradation products produced by α-and β-fibrinogenases of Trimeresurus mucrosquamatus snake venom
Muzaffar et al. Studies on fibrin formation and effects of dextran
US4177262A (en) Plasminogen compositions containing preactivated plasminogens with or without native plasminogens, process for making same, pharmaceutical compositions and control of blood clots
Silberman et al. Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity
Loeven The enzymes of the elastase complex
Próchniewicz et al. Chicken‐Gizzard Actin: Interaction with Skeletal‐Muscle Myosin
GB1581472A (en) Compounds of the plasminogen type processes for their production and pharmaceutical compositions containing them
Tangen et al. Study of the clotting, esterase and platelet aggregating activities of thrombin, acetylated thrombin and Reptilase®
Wojtecka-Lukasik et al. Adhesion of platelets to collagen devoid of telopeptides
Ikemori et al. Solubility of fibrin clots in monochloroacetic acid: a reflection of serum pepsinogen levels